Carolina Acute Care & Wellness Center, P.A.

11/15/2025

Renovations on Carolina Executive Park which is home to Carolina Acute Care & Wellness Center, P.A. continues.

Grand Opening of the 2nd floor suites projected to be complete early 2026. A few more upgrades to the 1st floor at Carolina Acute Care & Wellness Center are on schedule as well.

Renovations continuing. Projected completions early 2026.

11/11/2025

And Certified Hormone Centers like ours, also avoid synthetic formulations such as Progestin mentioned here as Progesterone, particularly micronized progesterone appears to be associated with even lower risks compared to synthetic progestins.

This is huge news in our field that some Ob/Gyn physicians have been lobbying for years to correct the misinformation of the Women's Health Initiative years ago that once guided therapy & training of physicians while ignoring current evidence.

The FDA says it will remove the "black box" warning labels on many hormone therapy drugs used to treat menopause and perimenopause. Dr. Tami Rowen, an associ...

11/11/2025

This Viewpoint describes the US Food and Drug Administration’s intended label updates and removal of black box warnings for menopausal hormone therapy based on current evidence.

11/11/2025

Studies have provided evidence that starting HRT within ten years of the onset of menopause can have numerous benefits which for most women outweigh potential risks.

Benefits include a reduced risk of all-cause mortality and fractures. HRT has also been associated with 50% reduction in heart attack risk, 64% reduction in cognitive decline, and 35% lower risk of Alzheimer’s.An analysis of 30 trials with 26,708 women participants found HRT was not associated with increased cancer mortality.

In fact, women who start HRT before age 60 appear to have a decreased mortality risk.

Secure .gov websites use HTTPS A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

11/11/2025

We've been expecting this for some time now.
Finally - the FDA has caught up with the Clinical evidence.

“Today, we are standing up for every woman who has symptoms of menopause and is looking to know her options and receive potentially life-changing treatment,” said Secretary Kennedy. “For more than two decades, bad science and bureaucratic inertia have resulted in women and physicians having an incomplete view of HRT. We are returning to evidence-based medicine and giving women control over their health again.”

“Tragically, tens of millions of women have been denied the life-changing and long-term health benefits of hormone replacement therapy because of a medical dogma rooted in a distortion of risk,” said FDA Commissioner Makary. “For too long, issues of women’s health have been underrecognized. Women and their physicians should make decisions based on data, not fear.”

The U.S. Department of Health and Human Services (HHS) today announced historic action to restore gold-standard science to women’s health.

11/11/2025

“With the exception of antibiotics and vaccines, there may be no medication in the modern world that can improve the health outcomes of older women on a population level more than hormone therapy,” FDA officials wrote in JAMA.

The FDA is reversing a 2003 decision that put a stringent warning on hormone therapy products for menopausal women, saying that the treatments offer heart, brain, and bone health benefits.

11/11/2025

"Over the past two decades, tens of millions of women have been denied or not offered hormone replacement therapy or have otherwise avoided it because of a medical dogma that it would increase their risk of dying of breast cancer. Clinical trials, however, don’t support that association. It’s time to treat women’s health with rigorous science instead of fear and misinformation" - Quote from WSJ Op Ed

Commissioner Marty Makary wrote in a Wall Street Journal op-ed on Monday that the FDA is removing black box warning labels from all-combined estrogen-progestogen, estrogen-only, other estrogen-containing, and progestogen-only products used for hormone therapy. The agency said it’s asking companies to remove the warnings from their products, specifically mentions of cardiovascular, dementia, and breast cancer risk.

“These labeling revisions signal a meaningful shift toward more nuanced, evidence-based communication of hormone therapy risks—one that prioritizes clinical relevance, distinguishes between different formulations and patient populations, and balances the narrative to reflect both safety and therapeutic value,” Makary wrote in a JAMA Viewpoint also released on Monday that was co-authored with FDA staff Christine Nguyen and Tracy Beth Høeg, as well as George Tidmarsh,

It alleviates menopause symptoms and provides long-term health benefits, but it has mistakenly been associated with fatal breast cancer.

11/10/2025

We will be closed Tuesday, Nov. 11th, in Honor of Veterans' Day.

Reopen Wednesday-

10/27/2025

Congratulations to Matthew & Maggie, who were married this weekend in Cleveland!

10/16/2025

Well, we didn't realize it was Boss' Day. Thank you to a great staff.

Your Boss's Day appreciation means alot - But truthfully, titles don't define leadership - teamwork does. We believe in leading by serving, growing by learning, and succeeding together. Thank you for making this a place where Excellence is shared and Purpose is lived out daily.

You are who we appreciate, & our prayer is that patients feel it as well.

10/08/2025

This study is still in the animal research phase. But we will be watching its progress closely.

🧠 Scientists reverse Alzheimer’s symptoms using nanoparticles that clear brain plaque and restore memory

In an astonishing breakthrough, researchers from Spain and China have developed nanoparticles that not only remove toxic Alzheimer’s plaques from the brain — but also repair the brain’s natural defense system.

The study, published in Signal Transduction and Targeted Therapy, showed that just three injections of these “supramolecular drugs” cleared up to 60 % of amyloid-beta buildup in only one hour in mice. Even more remarkably, within six months, animals suffering from severe memory loss began behaving normally again — effectively reversing half a year of cognitive decline.

What makes this discovery stand out is its focus on the blood–brain barrier (BBB) — the brain’s gatekeeper that becomes leaky and dysfunctional in Alzheimer’s. Instead of just dissolving plaque, the nanoparticles reactivate a key waste-clearing protein called LRP1, restoring the brain’s ability to flush out harmful material naturally. This dual action improves blood flow, reduces inflammation, and helps the brain reboot its self-healing processes.

Though still in early-stage animal testing, this research offers a bold new direction: tackling neurodegenerative diseases by repairing the body’s cleanup system — not just treating the symptoms. If these results translate to humans, they could mark a turning point in the fight against Alzheimer’s.

📖 Source:
Battaglia G., Tian X. et al. (2025). Signal Transduction and Targeted Therapy. Institute for Bioengineering of Catalonia & West China Hospital, Sichuan University.